nodes	percent_of_prediction	percent_of_DWPC	metapath
Carprofen—PTGS2—urinary bladder cancer	0.635	1	CbGaD
Carprofen—PTGS2—Cisplatin—urinary bladder cancer	0.0995	0.304	CbGbCtD
Carprofen—PTGS2—Etoposide—urinary bladder cancer	0.0978	0.298	CbGbCtD
Carprofen—PTGS1—Etoposide—urinary bladder cancer	0.0826	0.252	CbGbCtD
Carprofen—SLC22A6—Methotrexate—urinary bladder cancer	0.0478	0.146	CbGbCtD
Carprofen—Suprofen—UGT2B7—urinary bladder cancer	0.0026	0.232	CrCbGaD
Carprofen—Naproxen—UGT2B7—urinary bladder cancer	0.00204	0.182	CrCbGaD
Carprofen—Flurbiprofen—UGT2B7—urinary bladder cancer	0.00146	0.131	CrCbGaD
Carprofen—Ibuprofen—UGT2B7—urinary bladder cancer	0.0013	0.116	CrCbGaD
Carprofen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—urinary bladder cancer	0.00127	0.0475	CbGpPWpGaD
Carprofen—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—urinary bladder cancer	0.00117	0.0439	CbGpPWpGaD
Carprofen—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—urinary bladder cancer	0.001	0.0377	CbGpPWpGaD
Carprofen—PTGS1—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000859	0.0322	CbGpPWpGaD
Carprofen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000759	0.0285	CbGpPWpGaD
Carprofen—Ketoprofen—CXCL8—urinary bladder cancer	0.000749	0.0667	CrCbGaD
Carprofen—Ibuprofen—CXCL8—urinary bladder cancer	0.000737	0.0657	CrCbGaD
Carprofen—PTGS2—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000682	0.0256	CbGpPWpGaD
Carprofen—PTGS1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000602	0.0226	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—PTCRA—urinary bladder cancer	0.000547	0.0205	CbGpPWpGaD
Carprofen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO2—urinary bladder cancer	0.000532	0.02	CbGpPWpGaD
Carprofen—Ibuprofen—PPARG—urinary bladder cancer	0.000509	0.0454	CrCbGaD
Carprofen—PTGS1—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000457	0.0171	CbGpPWpGaD
Carprofen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—urinary bladder cancer	0.000441	0.0165	CbGpPWpGaD
Carprofen—Suprofen—PTGS2—urinary bladder cancer	0.000429	0.0383	CrCbGaD
Carprofen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—urinary bladder cancer	0.000414	0.0155	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—GSTZ1—urinary bladder cancer	0.00041	0.0154	CbGpPWpGaD
Carprofen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—urinary bladder cancer	0.000403	0.0151	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—GSTO2—urinary bladder cancer	0.000388	0.0146	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—NAT1—urinary bladder cancer	0.000388	0.0146	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000388	0.0146	CbGpPWpGaD
Carprofen—Fenoprofen—PTGS2—urinary bladder cancer	0.00037	0.033	CrCbGaD
Carprofen—PTGS2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000363	0.0136	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—UGT2B7—urinary bladder cancer	0.000355	0.0133	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—PTGS2—urinary bladder cancer	0.000345	0.013	CbGpPWpGaD
Carprofen—SLC22A6—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000345	0.0129	CbGpPWpGaD
Carprofen—Naproxen—PTGS2—urinary bladder cancer	0.000337	0.03	CrCbGaD
Carprofen—PTGS1—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.000335	0.0126	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—CYP4B1—urinary bladder cancer	0.00032	0.012	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000313	0.0117	CbGpPWpGaD
Carprofen—PTGS2—S1P1 pathway—RHOA—urinary bladder cancer	0.000303	0.0114	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000287	0.0108	CbGpPWpGaD
Carprofen—PTGS1—Eicosanoid Synthesis—PTGS2—urinary bladder cancer	0.000286	0.0107	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—BIRC3—urinary bladder cancer	0.000277	0.0104	CbGpPWpGaD
Carprofen—PTGS1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00027	0.0101	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.000266	0.00997	CbGpPWpGaD
Carprofen—Flurbiprofen—PTGS2—urinary bladder cancer	0.000241	0.0215	CrCbGaD
Carprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—urinary bladder cancer	0.00024	0.00899	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—MPO—urinary bladder cancer	0.000237	0.00888	CbGpPWpGaD
Carprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—urinary bladder cancer	0.000234	0.00879	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000233	0.00874	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000228	0.00855	CbGpPWpGaD
Carprofen—Ketoprofen—PTGS2—urinary bladder cancer	0.000218	0.0195	CrCbGaD
Carprofen—Ibuprofen—PTGS2—urinary bladder cancer	0.000215	0.0192	CrCbGaD
Carprofen—PTGS2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000215	0.00805	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—NAT2—urinary bladder cancer	0.000213	0.00798	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000188	0.00706	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000185	0.00694	CbGpPWpGaD
Carprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—urinary bladder cancer	0.000181	0.0068	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.00018	0.00677	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—urinary bladder cancer	0.000177	0.00663	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000175	0.00657	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000172	0.00645	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—HPGDS—urinary bladder cancer	0.00017	0.00638	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—GSTT1—urinary bladder cancer	0.000165	0.00619	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000164	0.00617	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000163	0.00611	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—urinary bladder cancer	0.000161	0.00603	CbGpPWpGaD
Carprofen—PTGS1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000159	0.00597	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000159	0.00596	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.000148	0.00555	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.000148	0.00555	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000143	0.00537	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000137	0.00512	CbGpPWpGaD
Carprofen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	0.000127	0.00477	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000127	0.00475	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000126	0.00473	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000124	0.00466	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000123	0.00463	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000123	0.00461	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—urinary bladder cancer	0.000123	0.0046	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000118	0.00443	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—urinary bladder cancer	0.000117	0.00439	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—GSTP1—urinary bladder cancer	0.000114	0.00429	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000112	0.00422	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000109	0.0041	CbGpPWpGaD
Carprofen—PTGS1—Biological oxidations—GSTM1—urinary bladder cancer	0.000105	0.00394	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000103	0.00387	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.000102	0.00382	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000101	0.0038	CbGpPWpGaD
Carprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.0001	0.00375	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	9.94e-05	0.00373	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	9.79e-05	0.00367	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	9.75e-05	0.00366	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	9.57e-05	0.00359	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	9.12e-05	0.00342	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	9.05e-05	0.00339	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	8.92e-05	0.00335	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	8.9e-05	0.00334	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	8.53e-05	0.0032	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	7.9e-05	0.00297	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	7.76e-05	0.00291	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	7.73e-05	0.0029	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	7.69e-05	0.00289	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	7.54e-05	0.00283	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	7.29e-05	0.00274	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	7.02e-05	0.00264	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	7e-05	0.00263	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.97e-05	0.00262	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	6.94e-05	0.0026	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	6.88e-05	0.00258	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	6.84e-05	0.00257	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—NAT1—urinary bladder cancer	6.64e-05	0.00249	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—GSTO2—urinary bladder cancer	6.64e-05	0.00249	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.53e-05	0.00245	CbGpPWpGaD
Carprofen—PTGS2—Disease—GSTO2—urinary bladder cancer	6.29e-05	0.00236	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	6.17e-05	0.00231	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	6.08e-05	0.00228	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	6.07e-05	0.00228	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	6.05e-05	0.00227	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	6.05e-05	0.00227	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	6.03e-05	0.00226	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	5.89e-05	0.00221	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	5.74e-05	0.00216	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	5.59e-05	0.0021	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	5.58e-05	0.00209	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	5.56e-05	0.00209	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	5.47e-05	0.00205	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	5.43e-05	0.00204	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.28e-05	0.00198	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—GSTO2—urinary bladder cancer	5.27e-05	0.00198	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—NAT1—urinary bladder cancer	5.27e-05	0.00198	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.22e-05	0.00196	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.18e-05	0.00195	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	5.16e-05	0.00194	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PRSS3—urinary bladder cancer	5.03e-05	0.00189	CbGpPWpGaD
Carprofen—PTGS2—Disease—SLC19A1—urinary bladder cancer	4.9e-05	0.00184	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	4.82e-05	0.00181	CbGpPWpGaD
Carprofen—PTGS2—Disease—PRSS3—urinary bladder cancer	4.77e-05	0.00179	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	4.75e-05	0.00178	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	4.61e-05	0.00173	CbGpPWpGaD
Carprofen—PTGS2—Disease—HDAC4—urinary bladder cancer	4.55e-05	0.00171	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	4.51e-05	0.00169	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.42e-05	0.00166	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	4.34e-05	0.00163	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	4.29e-05	0.00161	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	4.1e-05	0.00154	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.04e-05	0.00151	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—TYMP—urinary bladder cancer	4.02e-05	0.00151	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—PRSS3—urinary bladder cancer	4e-05	0.0015	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.91e-05	0.00147	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.86e-05	0.00145	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	3.78e-05	0.00142	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.78e-05	0.00142	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.77e-05	0.00142	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—NAT2—urinary bladder cancer	3.64e-05	0.00137	CbGpPWpGaD
Carprofen—PTGS2—Disease—LIG1—urinary bladder cancer	3.62e-05	0.00136	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.6e-05	0.00135	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.5e-05	0.00131	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.26e-05	0.00122	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.2e-05	0.0012	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—TYMP—urinary bladder cancer	3.19e-05	0.0012	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—RRM2—urinary bladder cancer	3.14e-05	0.00118	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.13e-05	0.00118	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.07e-05	0.00115	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.07e-05	0.00115	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.92e-05	0.0011	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—HPGDS—urinary bladder cancer	2.91e-05	0.00109	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—ENO2—urinary bladder cancer	2.91e-05	0.00109	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.9e-05	0.00109	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.89e-05	0.00109	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—NAT2—urinary bladder cancer	2.89e-05	0.00108	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—GSTT1—urinary bladder cancer	2.82e-05	0.00106	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.78e-05	0.00104	CbGpPWpGaD
Carprofen—PTGS2—Disease—ENO2—urinary bladder cancer	2.76e-05	0.00103	CbGpPWpGaD
Carprofen—PTGS2—Disease—RBX1—urinary bladder cancer	2.61e-05	0.000981	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.57e-05	0.000966	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—RRM2—urinary bladder cancer	2.49e-05	0.000936	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—NQO1—urinary bladder cancer	2.34e-05	0.00088	CbGpPWpGaD
Carprofen—PTGS2—Disease—JAG1—urinary bladder cancer	2.34e-05	0.000878	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—ENO2—urinary bladder cancer	2.31e-05	0.000866	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—HPGDS—urinary bladder cancer	2.31e-05	0.000866	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.3e-05	0.000861	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.27e-05	0.000854	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—GSTT1—urinary bladder cancer	2.24e-05	0.00084	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.21e-05	0.000828	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.98e-05	0.000744	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—GSTP1—urinary bladder cancer	1.96e-05	0.000734	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.89e-05	0.00071	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—NQO1—urinary bladder cancer	1.86e-05	0.000698	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—TYMS—urinary bladder cancer	1.82e-05	0.000682	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—NCOR1—urinary bladder cancer	1.8e-05	0.000674	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—GSTM1—urinary bladder cancer	1.8e-05	0.000674	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—GPX1—urinary bladder cancer	1.72e-05	0.000646	CbGpPWpGaD
Carprofen—PTGS2—Disease—NCOR1—urinary bladder cancer	1.7e-05	0.000639	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—ERCC2—urinary bladder cancer	1.69e-05	0.000634	CbGpPWpGaD
Carprofen—PTGS2—Disease—ERCC2—urinary bladder cancer	1.6e-05	0.000601	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1.59e-05	0.000596	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.57e-05	0.000591	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.55e-05	0.000583	CbGpPWpGaD
Carprofen—PTGS2—Disease—MTHFR—urinary bladder cancer	1.51e-05	0.000565	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.5e-05	0.000564	CbGpPWpGaD
Carprofen—PTGS2—Disease—TERT—urinary bladder cancer	1.5e-05	0.000563	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.44e-05	0.000542	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.43e-05	0.000535	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.43e-05	0.000535	CbGpPWpGaD
Carprofen—PTGS2—Disease—FGFR3—urinary bladder cancer	1.38e-05	0.000517	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.37e-05	0.000513	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.34e-05	0.000503	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.29e-05	0.000483	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.26e-05	0.000473	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.24e-05	0.000464	CbGpPWpGaD
Carprofen—PTGS2—Disease—CREBBP—urinary bladder cancer	1.17e-05	0.00044	CbGpPWpGaD
Carprofen—PTGS2—Disease—RHOA—urinary bladder cancer	1.06e-05	0.000398	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—PPARG—urinary bladder cancer	1.02e-05	0.000384	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.01e-05	0.00038	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—CREBBP—urinary bladder cancer	9.82e-06	0.000369	CbGpPWpGaD
Carprofen—PTGS2—Disease—ERBB2—urinary bladder cancer	9.82e-06	0.000369	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PTEN—urinary bladder cancer	8.84e-06	0.000332	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—EP300—urinary bladder cancer	8.43e-06	0.000316	CbGpPWpGaD
Carprofen—PTGS2—Disease—CDKN1A—urinary bladder cancer	8.39e-06	0.000315	CbGpPWpGaD
Carprofen—PTGS2—Disease—PTEN—urinary bladder cancer	8.37e-06	0.000314	CbGpPWpGaD
Carprofen—PTGS2—Disease—EP300—urinary bladder cancer	7.99e-06	0.0003	CbGpPWpGaD
Carprofen—PTGS2—Disease—SRC—urinary bladder cancer	7.77e-06	0.000291	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—PTEN—urinary bladder cancer	7.01e-06	0.000263	CbGpPWpGaD
Carprofen—PTGS2—Disease—MYC—urinary bladder cancer	6.96e-06	0.000261	CbGpPWpGaD
Carprofen—PTGS2—Disease—EGFR—urinary bladder cancer	6.81e-06	0.000255	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—EP300—urinary bladder cancer	6.69e-06	0.000251	CbGpPWpGaD
Carprofen—PTGS2—Disease—KRAS—urinary bladder cancer	6.43e-06	0.000241	CbGpPWpGaD
Carprofen—PTGS2—Disease—HRAS—urinary bladder cancer	5.47e-06	0.000205	CbGpPWpGaD
